Vetmedin® 1.25, 2.5, 5.0 mg Pimobendan capsules For Dogs

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

PIMOBENDAN (UNII: 34AP3BBP9T) (PIMOBENDAN - UNII:34AP3BBP9T)

Available from:

Boehringer Ingelheim Animal Health USA Inc.

Administration route:

ORAL

Prescription type:

PRESCRIPTION

Therapeutic indications:

1. For the treatment of congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency. It is recommended that the diagnosis of congestive heart failure be confirmed by radiographs or diuretic responsiveness. Treatment should be initiated only in symptomatic cases which will benefit from increased myocardial contractility (positive inotropy). 2. To delay the time of onset of congestive heart failure or sudden death in Doberman Pinscher dogs with clinically asymptomatic dilated cardiomyopathy. Clinically asymptomatic dilated cardiomyopathy is characterized by an increase in left ventricular end-systolic and end-diastolic diameter and should be diagnosed by means of a comprehensive cardiac examination (including echocardiographic examination and possibly Holter monitoring). Vetmedin® capsules should not be used in cases of hypertrophic cardiomyopathies or clinical conditions where an augmentation of cardiac output is not possible for functional or anatomical reasons (e.g. aortic ste

Product summary:

Vetmedin® 1.25 mg capsules Vetmedin® 2.5 mg capsules Vetmedin® 5.0 mg capsules

Authorization status:

unapproved drug other

Summary of Product characteristics

VETMEDIN- PIMOBENDAN CAPSULE
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
VETMEDIN®
1.25, 2.5, 5.0 MG
PIMOBENDAN CAPSULES
FOR DOGS
CLIENT INFORMATION SHEET
This Client Information Sheet contains important information about
VETMEDIN capsules,
a product used as a temporary replacement for US FDA-approved VETMEDIN
chewable
tablets.
VETMEDIN capsules are authorized for marketing in Canada to treat
congestive heart
failure in dogs. You should read this information before you start
giving VETMEDIN
capsules and review it each time the prescription is refilled as there
may be new
information.
This information sheet is provided only as a summary and does not take
the place of
instructions from your veterinarian. If you have received this product
from a pharmacy
and not directly from your veterinarian, you should contact your
veterinarian to inform
them that you have received this replacement product. TALK WITH YOUR
VETERINARIAN IF
YOU DO NOT UNDERSTAND ANY OF THIS INFORMATION OR IF YOU WANT TO KNOW
MORE
ABOUT VETMEDIN CAPSULES.
NOTE TO PRESCRIBING VETERINARIANS
The dose administered should be as stated in the FDA approved VETMEDIN
chewable
tablets package insert, accessible at:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5441e5b2-cdc0-477a-bd9a-
ec5f8d912281
WHY DID I RECEIVE VETMEDIN CAPSULES?
Because of a shortage in the supply of the FDA-approved VETMEDIN
chewable tablets,
the FDA is allowing temporary use of VETMEDIN capsules in the United
States.
ARE VETMEDIN CAPSULES THE SAME AS VETMEDIN CHEWABLE TABLETS?
•
•
CLIENT INFORMATION SHEET FOR VETMEDIN® (PIMOBENDAN) CAPSULES
Replacement product for Vetmedin® (pimobendan) chewable tablets
CONTACT YOUR VETERINARIAN BEFORE ADMINISTERING THIS PRODUCT TO YOUR
DOG.
The active ingredient in VETMEDIN capsules is pimobendan, just like in
Vetmedin
chewable tablets, th